Risk Factors Associated with Mortality in Hospitalized Patients with COVID-19 during the Omicron Wave in Brazil

Considering the imminence of new SARS-CoV-2 variants and COVID-19 vaccine availability, it is essential to understand the impact of the disease on the most vulnerable groups and those at risk of death from the disease. To this end, the odds ratio (OR) for mortality and hospitalization was calculated...

Full description

Bibliographic Details
Main Authors: Marilaine Colnago, Giovana A. Benvenuto, Wallace Casaca, Rogério G. Negri, Eder G. Fernandes, José A. Cuminato
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Bioengineering
Subjects:
Online Access:https://www.mdpi.com/2306-5354/9/10/584
_version_ 1827651528313274368
author Marilaine Colnago
Giovana A. Benvenuto
Wallace Casaca
Rogério G. Negri
Eder G. Fernandes
José A. Cuminato
author_facet Marilaine Colnago
Giovana A. Benvenuto
Wallace Casaca
Rogério G. Negri
Eder G. Fernandes
José A. Cuminato
author_sort Marilaine Colnago
collection DOAJ
description Considering the imminence of new SARS-CoV-2 variants and COVID-19 vaccine availability, it is essential to understand the impact of the disease on the most vulnerable groups and those at risk of death from the disease. To this end, the odds ratio (OR) for mortality and hospitalization was calculated for different groups of patients by applying an adjusted logistic regression model based on the following variables of interest: gender, booster vaccination, age group, and comorbidity occurrence. A massive number of data were extracted and compiled from official Brazilian government resources, which include all reported cases of hospitalizations and deaths associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Brazil during the “wave” of the Omicron variant (BA.1 substrain). Males (1.242; 95% CI 1.196–1.290) aged 60–79 (3.348; 95% CI 3.050–3.674) and 80 years or older (5.453; 95% CI 4.966–5.989), and hospitalized patients with comorbidities (1.418; 95% CI 1.355–1.483), were more likely to die. There was a reduction in the risk of death (0.907; 95% CI 0.866–0.951) among patients who had received the third dose of the anti-SARS-CoV-2 vaccine (booster). Additionally, this big data investigation has found statistical evidence that vaccination can support mitigation plans concerning the current scenario of COVID-19 in Brazil since the Omicron variant and its substrains are now prevalent across the entire country.
first_indexed 2024-03-09T20:40:55Z
format Article
id doaj.art-8b1b270a666141548d92ec77566fb4dc
institution Directory Open Access Journal
issn 2306-5354
language English
last_indexed 2024-03-09T20:40:55Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Bioengineering
spelling doaj.art-8b1b270a666141548d92ec77566fb4dc2023-11-23T22:58:15ZengMDPI AGBioengineering2306-53542022-10-0191058410.3390/bioengineering9100584Risk Factors Associated with Mortality in Hospitalized Patients with COVID-19 during the Omicron Wave in BrazilMarilaine Colnago0Giovana A. Benvenuto1Wallace Casaca2Rogério G. Negri3Eder G. Fernandes4José A. Cuminato5Institute of Chemistry, São Paulo State University (UNESP), Araraquara 14800-060, BrazilFaculty of Science and Technology (FCT), São Paulo State University (UNESP), Presidente Prudente 19060-900, BrazilInstitute of Biosciences, Letters and Exact Sciences, São Paulo State University (UNESP), São José do Rio Preto 15054-000, BrazilScience and Technology Institute, São Paulo State University (UNESP), São José dos Campos 12247-004, BrazilImmunization Division—Centre of Epidemiology Surveillance of the São Paulo State Health Department, São Paulo 01246-000, BrazilInstitute of Mathematics and Computer Science, São Paulo University (USP), São Carlos 13566-590, BrazilConsidering the imminence of new SARS-CoV-2 variants and COVID-19 vaccine availability, it is essential to understand the impact of the disease on the most vulnerable groups and those at risk of death from the disease. To this end, the odds ratio (OR) for mortality and hospitalization was calculated for different groups of patients by applying an adjusted logistic regression model based on the following variables of interest: gender, booster vaccination, age group, and comorbidity occurrence. A massive number of data were extracted and compiled from official Brazilian government resources, which include all reported cases of hospitalizations and deaths associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Brazil during the “wave” of the Omicron variant (BA.1 substrain). Males (1.242; 95% CI 1.196–1.290) aged 60–79 (3.348; 95% CI 3.050–3.674) and 80 years or older (5.453; 95% CI 4.966–5.989), and hospitalized patients with comorbidities (1.418; 95% CI 1.355–1.483), were more likely to die. There was a reduction in the risk of death (0.907; 95% CI 0.866–0.951) among patients who had received the third dose of the anti-SARS-CoV-2 vaccine (booster). Additionally, this big data investigation has found statistical evidence that vaccination can support mitigation plans concerning the current scenario of COVID-19 in Brazil since the Omicron variant and its substrains are now prevalent across the entire country.https://www.mdpi.com/2306-5354/9/10/584COVID-19mortalityrisk factorshospitalizationOmicron
spellingShingle Marilaine Colnago
Giovana A. Benvenuto
Wallace Casaca
Rogério G. Negri
Eder G. Fernandes
José A. Cuminato
Risk Factors Associated with Mortality in Hospitalized Patients with COVID-19 during the Omicron Wave in Brazil
Bioengineering
COVID-19
mortality
risk factors
hospitalization
Omicron
title Risk Factors Associated with Mortality in Hospitalized Patients with COVID-19 during the Omicron Wave in Brazil
title_full Risk Factors Associated with Mortality in Hospitalized Patients with COVID-19 during the Omicron Wave in Brazil
title_fullStr Risk Factors Associated with Mortality in Hospitalized Patients with COVID-19 during the Omicron Wave in Brazil
title_full_unstemmed Risk Factors Associated with Mortality in Hospitalized Patients with COVID-19 during the Omicron Wave in Brazil
title_short Risk Factors Associated with Mortality in Hospitalized Patients with COVID-19 during the Omicron Wave in Brazil
title_sort risk factors associated with mortality in hospitalized patients with covid 19 during the omicron wave in brazil
topic COVID-19
mortality
risk factors
hospitalization
Omicron
url https://www.mdpi.com/2306-5354/9/10/584
work_keys_str_mv AT marilainecolnago riskfactorsassociatedwithmortalityinhospitalizedpatientswithcovid19duringtheomicronwaveinbrazil
AT giovanaabenvenuto riskfactorsassociatedwithmortalityinhospitalizedpatientswithcovid19duringtheomicronwaveinbrazil
AT wallacecasaca riskfactorsassociatedwithmortalityinhospitalizedpatientswithcovid19duringtheomicronwaveinbrazil
AT rogeriognegri riskfactorsassociatedwithmortalityinhospitalizedpatientswithcovid19duringtheomicronwaveinbrazil
AT edergfernandes riskfactorsassociatedwithmortalityinhospitalizedpatientswithcovid19duringtheomicronwaveinbrazil
AT joseacuminato riskfactorsassociatedwithmortalityinhospitalizedpatientswithcovid19duringtheomicronwaveinbrazil